73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit: Pixabay/CC0 Public DomainA research team at Helmholtz Munich has revealed a specific mechanism that is able to promote c

Team reveals specific mechanism for promoting cancer vulnerability to ferroptosis

by Luisa Hoffmann,Helmholtz Association of German Research CentresCredit: Pixabay/CC0 Public DomainA research team at Helmholtz Munich has revealed a specific mechanism that is able to promote c
Research provides critical information about size and growth speed of gliomas

Research provides critical information about size and growth speed of gliomas

by Kelley Luckstein,Mayo ClinicCredit: Mayo ClinicAn important new clue for preventing and treating brain tumors known as gliomas has been identified in research led by the Lunenfeld-Tannenbaum

Research provides critical information about size and growth speed of gliomas

by Kelley Luckstein,Mayo ClinicCredit: Mayo ClinicAn important new clue for preventing and treating brain tumors known as gliomas has been identified in research led by the Lunenfeld-Tannenbaum
Public unaware of cancer risk from too little exercise, study reports

Public unaware of cancer risk from too little exercise, study reports

by Taylor & FrancisCredit: CC0 Public DomainIt has long been accepted that regular exercise can assist in helping to prevent or reduce the risk of a multitude of health problems. However, a n

Public unaware of cancer risk from too little exercise, study reports

by Taylor & FrancisCredit: CC0 Public DomainIt has long been accepted that regular exercise can assist in helping to prevent or reduce the risk of a multitude of health problems. However, a n
Immunotherapy was meant to defeat cancer—what happened to the great promise?

Immunotherapy was meant to defeat cancer—what happened to the great promise?

by Jonathan Fisher,The ConversationCredit: Ivan Samkov from PexelsIn 1893, theAmerican Journal of the Medical Sciencesreported on 10 patients whose large and hitherto incurable cance

Immunotherapy was meant to defeat cancer—what happened to the great promise?

by Jonathan Fisher,The ConversationCredit: Ivan Samkov from PexelsIn 1893, theAmerican Journal of the Medical Sciencesreported on 10 patients whose large and hitherto incurable cance
Researchers demonstrate in mice a new way to deliver medication to malignant brain tumors

Researchers demonstrate in mice a new way to deliver medication to malignant brain tumors

by Brown UniversityCredit:Journal of Controlled Release(2022). DOI: 10.1016/j.jconrel.2022.10.051Researchers have demonstrated in mice a new approach for delivering medication across

Researchers demonstrate in mice a new way to deliver medication to malignant brain tumors

by Brown UniversityCredit:Journal of Controlled Release(2022). DOI: 10.1016/j.jconrel.2022.10.051Researchers have demonstrated in mice a new approach for delivering medication across
Novel checklist for 'quality of life' to take cancer clinical trials to the next level

Novel checklist for 'quality of life' to take cancer clinical trials to the next level

byEuropean Society for Medical OncologyCredit:Annals of Oncology(2022). DOI: 10.1016/j.annonc.2022.12.004The European Society for Medical Oncology (ESMO) has developed a quality of l

Novel checklist for 'quality of life' to take cancer clinical trials to the next level

byEuropean Society for Medical OncologyCredit:Annals of Oncology(2022). DOI: 10.1016/j.annonc.2022.12.004The European Society for Medical Oncology (ESMO) has developed a quality of l
Active surveillance feasible for small, low-grade bladder cancer

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F

Active surveillance feasible for small, low-grade bladder cancer

(HealthDay)—For patients who present with small, low-grade pTa/pT1a recurrent papillary bladder tumors, active surveillance appears to be a reasonable strategy, according to a study published in the F
Study illuminates precancerous 'clonal outgrowth' in blood cells

Study illuminates precancerous 'clonal outgrowth' in blood cells

byWeill Cornell Medical CollegeCredit: CC0 Public DomainA common, spontaneous mutation in blood stem cells, which has been linked to higher risks of blood cancer and cardiovascular disease, may

Study illuminates precancerous 'clonal outgrowth' in blood cells

byWeill Cornell Medical CollegeCredit: CC0 Public DomainA common, spontaneous mutation in blood stem cells, which has been linked to higher risks of blood cancer and cardiovascular disease, may
A hidden route for fatty acids can make cancers resistant to therapy

A hidden route for fatty acids can make cancers resistant to therapy

by VIB (the Flanders Institute for Biotechnology)Killer T cells surround a cancer cell. Credit: NIHFatty acid metabolism is an essential process in tumor growth and proliferation. Despite attempt

A hidden route for fatty acids can make cancers resistant to therapy

by VIB (the Flanders Institute for Biotechnology)Killer T cells surround a cancer cell. Credit: NIHFatty acid metabolism is an essential process in tumor growth and proliferation. Despite attempt
The protein behind immunotherapy resistance

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im
Novel genomics tool enables more accurate identification of rare mutations in cancer cells

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s

Novel genomics tool enables more accurate identification of rare mutations in cancer cells

by New York Genome CenterExample of colored de Bruijn graph rendered to represent genomic data for a short region of 400 base pairs using the Lancet genomics tool developed by New York Genome Center s
Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients

Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients

by SingHealthCredit: Pixabay/CC0 Public DomainAn international randomized controlled trial, advised by a steering committee co-led by a senior clinician-scientist from the National Cancer Centre

Clinical trial of adjuvant therapy combination shows improved recurrence-free survival in liver cancer patients

by SingHealthCredit: Pixabay/CC0 Public DomainAn international randomized controlled trial, advised by a steering committee co-led by a senior clinician-scientist from the National Cancer Centre